Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Apr 3;14(1):5.
doi: 10.1186/s13010-019-0074-7.

Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health

Affiliations

Utilitarianism and the ethical foundations of cost-effectiveness analysis in resource allocation for global health

Elliot Marseille et al. Philos Ethics Humanit Med. .

Abstract

Efficiency as quantified and promoted by cost-effectiveness analysis sometimes conflicts with equity and other ethical values, such as the "rule of rescue" or rights-based ethical values. We describe the utilitarian foundations of cost-effectiveness analysis and compare it with alternative ethical principles. We find that while fallible, utilitarianism is usually superior to the alternatives. This is primarily because efficiency - the maximization of health benefits under a budget constraint - is itself an important ethical value. Other ethical frames may be irrelevant, incompatible with each other, or have unacceptable implications. When alternatives to efficiency are considered for precedence, we propose that it is critical to quantify the trade-offs, in particular, the lost health benefits associated with divergence from strict efficiency criteria. Using an example from HIV prevention in a high-prevalence African country, we show that favoring a rights-based decision could result in 92-118 added HIV infections per $100,000 of spending, compared to one based on cost-effectiveness.

Keywords: Cost-effectiveness; Ethics; Global health; Health economics; Utilitarianism.

PubMed Disclaimer

Conflict of interest statement

Authors’ information

EAM is principal of the firm, Health Strategies International, that specializes in the economic evaluation of both global and domestic public health programs. Trained in health policy analysis, Dr. Marseille has over 30 years of senior public health management and research experience with a focus on the empirical and modeled assessment of the cost and cost-effectiveness of programs, and policies related to HIV/AIDS and other diseases relevant to global health. JGK is Emeritus Professor at the Philip R. Lee Institute for Health Policy Studies, the Institute for Global Health Sciences, and the Department of Epidemiology and Biostatistics, all at UCSF. Dr. Kahn is an expert in cost-effectiveness analysis, evidence-based medicine, and policy modeling in health care. His work focuses on the use of cost-effectiveness analysis to inform decision-making in public health and medicine. He is a widely published expert in the economic assessment of HIV prevention and treatment programs and on a wide range of other global health issues.

Ethics approval and consent to participate

Not relevant. No human or animal subjects were needed or used.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Likelihood of convergence between ethical principles

References

    1. Jamison DT. Disease control priorities, 3rd edition: improving health and reducing poverty. Lancet. 2018;391(10125):e11-e4. - PubMed
    1. Musgrove P. Public spending on health care: how are different criteria related? Health Policy. 1999;47(3):207–223. doi: 10.1016/S0168-8510(99)00024-X. - DOI - PubMed
    1. Neumann PJ, Weinstein MC. Legislating against use of cost-effectiveness information. N Engl J Med. 2010;363(16):1495–1497. doi: 10.1056/NEJMp1007168. - DOI - PubMed
    1. Rutstein SE, Price JT, Rosenberg NE, Rennie SM, Biddle AK, Miller WC. Hidden costs: the ethics of cost-effectiveness analyses for health interventions in resource-limited settings. Glob Public Health. 2017;12(10):1269–81. - PMC - PubMed
    1. Roberts MJ, Reich MR. Ethical analysis in public health. Lancet. 2002;359(9311):1055–1059. doi: 10.1016/S0140-6736(02)08097-2. - DOI - PubMed

MeSH terms